Back to Agenda
Perspectives on Medication Errors
Session Chair(s)
Vicki Edwards, RPh
Vice President, Pharmacovigilance Excellence and International QPPV, Abbvie, United Kingdom
Medication errors cause a large number of adverse drug reactions (ADRs) with negative patient health outcomes each year. The new pharmacovigilance legislation expanded the obligations related to medication error which presents some interesting challenges. This session will look at: • Real experiences from the perspective of a regulatory authority • Practical challenges for the industry related to coding of medication errors • Perspectives of patients and healthcare professionals
Speaker(s)
Claudia Kayser
Regulatory Affairs Manager, Pharmaceutical-Pharmacological Assessor, BfArM, Germany
Medication Errors Provide a Challenge for Pharmacovigilance – Experiences of a Regulatory Authority
Maren Enssle, RN
Meddra Specialist, Abbott Laboratories, Germany
How Do MedDRA Terminology Changes Affect Our Data / Our Interpretation of Verbatims Associated with Off-Label Use
Kristina Strutt, MD, MA, MRCP, FFPM
Senior Vice President, Ipsen Biopharm Limited, United Kingdom
Medication Errors – The Perspective of Patients and Healthcare Professionals Relating to Identification of Issues and Collection of Data
Have an account?